Therapeutic efficacy of sitafloxacin against Pseudomonas aeruginosa in a rat model of urinary tract infection

被引：2
|
作者：
Kurosaka, Y
Ishida, Y
Yamamura, E
Otani, T
Kumon, H
机构：
[1] Daiichi Pharmaceut Co Ltd, New Prod Res Labs 1, Edogawa Ku, Tokyo 1348630, Japan
[2] Okayama Univ, Sch Med, Dept Urol, Okayama 700, Japan
来源：
DRUGS | 1999年 / 58卷 / Suppl 2期
关键词：
D O I：
10.2165/00003495-199958002-00145
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：412 / 414
页数：3
相关论文
共 50 条
  • [31] Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection
    Omri, A
    Suntres, ZE
    Shek, PN
    BIOCHEMICAL PHARMACOLOGY, 2002, 64 (09) : 1407 - 1413
  • [32] Efficacy of Ceftobiprole Medocaril against Enterococcus faecalis in a Murine Urinary Tract Infection Model
    Singh, Kavindra V.
    Murray, Barbara E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 3457 - 3460
  • [33] Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection
    Preston, MJ
    Gerceker, AA
    Koles, NL
    Pollack, M
    Pier, GB
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (07) : 1418 - 1425
  • [34] In-vivo efficacy of a novel Leu-t-RNA synthatase inhibitor compound a against MDR Pseudomonas aeruginosa 1594965 in a foreign body associated urinary tract infection model
    Kumar, M.
    Rao, M.
    Barman, T. K.
    Pandya, M.
    Dube, S.
    Purnapatre, K. P.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 45 : 129 - 129
  • [35] Genotypic identification of Pseudomonas aeruginosa strains isolated from patients with urinary tract infection
    Estaji, Mohammad
    Tabasi, Mohsen
    Heravi, Fatemah Sadeghpour
    Khezerloo, Jamil Kheirvari
    Radmanesh, Amin
    Raheb, Jamshid
    Ghadirzadeh, Mohammad Reza
    Tabatabaei, Azardokht
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2019, 65 : 23 - 28
  • [36] Pseudomonas Aeruginosa Urinary Tract Infection in Children: Risk Factors and Outcomes EDITORIAL COMMENT
    Guerra, Luis
    JOURNAL OF UROLOGY, 2012, 187 (01): : 264 - 264
  • [37] EFFECT OF CARBENICILLIN, GENTAMICIN, AND THEIR COMBINATION ON EXPERIMENTAL PSEUDOMONAS-AERUGINOSA URINARY TRACT INFECTION
    KONICKOVA, L
    PRAT, V
    JOURNAL OF CLINICAL PATHOLOGY, 1971, 24 (02) : 113 - +
  • [38] Contribution of Tamm-Horsfall protein to virulence of Pseudomonas aeruginosa in urinary tract infection
    Harjai, K
    Mittal, R
    Chhibber, S
    Sharma, S
    MICROBES AND INFECTION, 2005, 7 (01) : 132 - 137
  • [39] In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model
    Morinaga, Yoshitomo
    Yanagihara, Katsunori
    Nakamura, Shigeki
    Yamamoto, Kazuko
    Izumikawa, Koichi
    Seki, Masafumi
    Kakeya, Hiroshi
    Yamamoto, Yoshihiro
    Yamada, Yasuaki
    Kohno, Shigeru
    Kamihira, Shimeru
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1326 - 1331
  • [40] DEFENSES OF URINARY TRACT AGAINST INFECTION - A MATHEMATICAL MODEL
    DUGDALE, AE
    INVESTIGATIVE UROLOGY, 1969, 6 (04): : 371 - +
12345